Finding 618504 (2022-004)

Material Weakness
Requirement
P
Questioned Costs
-
Year
2022
Accepted
2023-09-27
Audit: 45576
Organization: Rikarbon, Inc. (DE)

AI Summary

  • Core Issue: The Company lacks formal non-discrimination and drug-free workplace policies.
  • Impacted Requirements: Federal compliance mandates these policies and signed employee acknowledgements.
  • Recommended Follow-Up: Ensure all employees sign acknowledgements for these policies during the hiring process.

Finding Text

2022-004: EMPLOYEE FILES Criteria: Federal compliance requirements dictate that drug-free workplace policy and non-discrimination policy be in place. Condition: The Company did not have a formal non-discrimination or drug free workplace policy in place. Cause: The Company did not obtain signed acknowledgements from employees for either policy in 2022. Effect: The Company did not comply with non-discrimination and drug free workplace requirements. Questioned Costs: N/A Perspective Information: The issue is considered to be isolated to employee files. Repeat Findings: Not a repeat finding. Context: Testing was conducted on four out of nine employee files for the reporting period. 100% of the files tested had deviations from requirement. Recommendation: The Company should obtain signed acknowledgements from all employees upon hiring. View of Responsible Officials and Planned Corrective Action: The Company will obtain signed acknowledgements from all employees upon hiring.

Categories

Reporting

Other Findings in this Audit

  • 42056 2022-003
    Material Weakness
  • 42057 2022-004
    Material Weakness
  • 42058 2022-005
    Material Weakness
  • 42059 2022-006
    Material Weakness
  • 42060 2022-007
    Material Weakness
  • 42061 2022-003
    Material Weakness
  • 42062 2022-004
    Material Weakness
  • 42063 2022-005
    Material Weakness
  • 42064 2022-006
    Material Weakness
  • 42065 2022-007
    Material Weakness
  • 42066 2022-003
    Material Weakness
  • 42067 2022-004
    Material Weakness
  • 42068 2022-005
    Material Weakness
  • 42069 2022-006
    Material Weakness
  • 42070 2022-007
    Material Weakness
  • 42071 2022-003
    Material Weakness
  • 42072 2022-004
    Material Weakness
  • 42073 2022-005
    Material Weakness
  • 42074 2022-006
    Material Weakness
  • 42075 2022-007
    Material Weakness
  • 618498 2022-003
    Material Weakness
  • 618499 2022-004
    Material Weakness
  • 618500 2022-005
    Material Weakness
  • 618501 2022-006
    Material Weakness
  • 618502 2022-007
    Material Weakness
  • 618503 2022-003
    Material Weakness
  • 618505 2022-005
    Material Weakness
  • 618506 2022-006
    Material Weakness
  • 618507 2022-007
    Material Weakness
  • 618508 2022-003
    Material Weakness
  • 618509 2022-004
    Material Weakness
  • 618510 2022-005
    Material Weakness
  • 618511 2022-006
    Material Weakness
  • 618512 2022-007
    Material Weakness
  • 618513 2022-003
    Material Weakness
  • 618514 2022-004
    Material Weakness
  • 618515 2022-005
    Material Weakness
  • 618516 2022-006
    Material Weakness
  • 618517 2022-007
    Material Weakness

Programs in Audit

ALN Program Name Expenditures
81.049 Office of Science Financial Assistance Program $195,323